5,193
Views
33
CrossRef citations to date
0
Altmetric
Original Articles

Formulation and evaluation of Cyclosporin A emulgel for ocular delivery

, , , , &
Pages 911-917 | Received 27 Aug 2013, Accepted 30 Oct 2013, Published online: 08 Jan 2014

Figures & data

Figure 1. Viscosity-shear rate profiles of CsA emulgel.

Figure 1. Viscosity-shear rate profiles of CsA emulgel.

Table 1. The stability of CsA emulgel.

Figure 2. The effects of concentration and viscosity of gel on the release behavior of CsA emulgel.

Figure 2. The effects of concentration and viscosity of gel on the release behavior of CsA emulgel.

Figure 3. Concentration–time profiles of CsA in tear fluid after instillation in conscious rabbits (n = 5).

Figure 3. Concentration–time profiles of CsA in tear fluid after instillation in conscious rabbits (n = 5).

Table 2. Parameters based on statistical moment theory for CsA in tear fluid after topical administration in conscious rabbits (n = 6).

Table 3. Mean tear concentration of CsA after instillation of E-gel preparation and castor oil preparation in rabbit(mg/ml, X¯±SD, n = 6).

Figure 4. Light microscopy of rabbit’s iris (A, B), rabbit’s conjunctiva (C, D), and rabbit’s corneal tissue sections (E, F), from CsA emulgel-treated (OD) and control (OS) rabbit eyes. Samples and tissue sections from treated eyes showed no alterations in morphological details compared to control eyes. Eye tissues from CsA emulgel-treated animals gave similar results. Staining: (A–F) hematoxylin-eosin. Scale bar = 100 μm.

Figure 4. Light microscopy of rabbit’s iris (A, B), rabbit’s conjunctiva (C, D), and rabbit’s corneal tissue sections (E, F), from CsA emulgel-treated (OD) and control (OS) rabbit eyes. Samples and tissue sections from treated eyes showed no alterations in morphological details compared to control eyes. Eye tissues from CsA emulgel-treated animals gave similar results. Staining: (A–F) hematoxylin-eosin. Scale bar = 100 μm.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.